Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06018129 |
| Title | A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Genmab |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
| University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Peter MacCallum Cancer Institute trading as Peter MacCallum Cancer Centre | Melbourne | Victoria | Australia | Details |